Radiopharmaceuticals developer Precirix completed an $88m series B round featuring Novo while corporate-backed kitchen technology provider Bear Robotics raised $81m.

Funding

Belgium-based precision radiopharmaceuticals developer Precirix closed an €80m ($88m) series B round yesterday backed by pharmaceutical firm Novo. The round was co-led by Inkef Capital, Jeito Capital and Forbion, and additionally included V-Bio Ventures, Gimv, HealthCap, Pontifax Venture Capital, BioMed Partners and all its seed-stage investors, of which only Fournier-Majoie Foundation had been previously identified.

Bear Robotics, a US-based restaurant robotics technology developer backed by telecommunications and internet group SoftBank, conglomerate Lotte Group, video game publisher Smilegate, seat frame…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Robert Lavine

Robert Lavine is special features editor for Global Venturing.
Email LinkedIn